Telisotuzumab Vedotin Approved for NSCLC ...Middle East

Medscape - News
Telisotuzumab Vedotin Approved for NSCLC
The antibody-drug conjugate is approved for previously treated advanced NSCLC patients with high c-Met protein overexpression. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Telisotuzumab Vedotin Approved for NSCLC )

Also on site :